RT Book, Section A1 Whalen, Karen A1 Sando, Karen A2 Angaran, David M. A2 Whalen, Karen SR Print(0) ID 1102489034 T1 Diabetes Mellitus Medication Therapy Management Data Set T2 Medication Therapy Management: A Comprehensive Approach YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 9780071848695 LK accesspharmacy.mhmedical.com/content.aspx?aid=1102489034 RD 2024/03/29 AB Intensive glycemic control can reduce microvascular complications of diabetes.The hemoglobin A1c goal for most patients is less than 7%; however, goals for glycemic control should be individualized based on presence of concurrent illness or complications, risk of hypoglycemia, and life expectancy.To reduce macrovascular complications, management of cardiac risk factors such as hyperten-sion and hyperlipidemia is necessary; glycemic control alone is unlikely to prevent cardiovascular morbidity and mortality.MTM providers should work with patients and the healthcare team to tailor medication regimens that achieve therapeutic goals, promote adherence, reduce the risk of complications, and maximize quality of life for patients with diabetes.